NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/26/2026 14:58
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization147.68 mln
Float18.39 mln
Earnings Date11/11/2026
Piotroski F-Score
4
/ 9
Borderline
1-Year Forecast
24.00
Transformational upside
Relative Strength
19
/ 100
Significantly lagging
Debt / Equity
0.00
Debt-free
ROE
-54.77
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
LENZ Therapeutics is a US-based pharmaceutical company dedicated to helping adults see more clearly as they age. Founded in 2013 and based in Solana Beach, California, the company is working to bring new eye drop treatments to market that address presbyopia, the gradual loss of near vision that affects most people in middle age. Its leading treatments, VIZZ and LNZ101, are designed to offer patients a practical alternative to reading glasses.
